AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.50
-1.52 (-2.67%)
May 29, 2026, 1:18 PM EDT - Market open
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.62 billion as of May 29, 2026. Its market cap has increased by 167.89% in one year.
Market Cap
1.62B
Enterprise Value
1.65B
1-Year Change
167.89%
Ranking
Category
Stock Price
$55.50
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.62B, an increase of 423.19%. That is a compound annual growth rate of 19.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.66B | 23.62% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.71B |
| Taysha Gene Therapies | 1.70B |
| Novavax | 1.70B |
| Capricor Therapeutics | 1.69B |
| Generate Biomedicines | 1.68B |
| Palvella Therapeutics | 1.66B |
| Nuvation Bio | 1.65B |
| Monte Rosa Therapeutics | 1.64B |